Peramivir for influenza

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Australian Prescriber

• Publication date

  2019-06-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.18773/austprescr.2019.047PMID 31427848PMCID 6698233
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influenza: overview on prevention and therapy.

  2019cited by this paper
• Phase III Randomized, Double-Blind Study Comparing Single-Dose Intravenous Peramivir with Oral Oseltamivir in Patients with Seasonal Influenza Virus Infection

  2011cited by this paper
• Efficacy and Safety of Intravenous Peramivir for Treatment of Seasonal Influenza Virus Infection

  2010cited by this paper

• Antiviral treatment for viral pneumonia: current drugs and natural compounds

  2025cites this paper
• Novel RP-HPLC method for quantification of peramivir and its impurity (1H-1,2,4-triazole-1-carboximidamide) in bulk and injectable preparations

  2025influential citation
• Evolution of Influenza Viruses—Drug Resistance, Treatment Options, and Prospects

  2022cites this paper
• Pharmacokinetic behavior of peramivir in the plasma and lungs of rats after trans-nasal aerosol inhalation and intravenous injection.

  2020cites this paper
• Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses

  2020cites this paper